AtriCure, Inc. creates, produces, and markets medical devices for the surgical treatment of cardiac tissue and intercostal nerves.
Atricure stock last closed at $59.88, up 0.89% from the previous day, and has increased 77.52% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.69 percentage points. Atricure stock is currently +136.03% from its 52-week low of $25.37, and -4.95% from its 52-week high of $63.00.
There are currently 50.87M shares of ATRC outstanding. The market capitalization of ATRC is $3.05B. In the last 24 hours, 1.12M ATRC shares were traded.
How to Buy Atricure Stock
Not sure how to invest in Atricure stock? Here's how.
Choose where to buy Atricure stock: You need to pick an online brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you determine where to buy Atricure stock.
Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Fund your brokerage account: Choose your payment method and add your info.
Evaluate Atricure stock: The Atricure ticker symbol is ATRC. Is Atricure stock a good investment? Should you buy shares of ATRC? How do ATRC's underlying business fundamentals look? Do top analysts think Atricure is a good buy? Why has ATRC's stock price moved recently? (Hint: Our stock market research tools can help you decide if ATRC is a good stock to buy).
Place your ATRC trade: Decide if you will purchase ATRC shares at the current market price or use a limit order to purchase ATRC shares at a specific price.
Watch your investment in ATRC: Create a watchlist to the latest updates on your new investment in Atricure shares.
Step 1: Choose where to buy Atricure stock
You need a brokerage account to access the NASDAQ market and buy ATRC stock.
A brokerage account is an investment account that enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our experience, eToro is the best stock brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to global markets: From Tech to Financial Services, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've selected your brokerage, it's time to fill out some personal info so you are able to invest in ATRC stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Atricure stock
Once you have chosen the best place to buy Atricure stock, it's very important to evaluate their stock before you buy, so you can understand the risk and upside.
Atricure shares data
ATRC Price
$59.88
1w %
-1.79%
1y %
77.52%
5y %
-22.97%
P/E
285.14x
P/B
5.9x
P/S
5.12x
PEG
5.62x
Revenue
$569.62M
Earnings
$10.55M
Fore. Rev. Growth
10.97%
Fore. Earn. Growth
50.75%
Market Cap
$3.05B
Next Earnings
N/A
Next Dividend
N/A
ATRC Due Diligence Score
WallStreetZen was created to help part-time investors perform better fundamental analysis in less time.
ATRC profit margin has gone up from -7.3% to 1.9% in the past year.
There are more short-term assets than long-term liabilities on the ATRC balance sheet.
ATRC's operating cash flow of $64.94M allows it to safely service it's debt of $71.05M.
ATRC has a low debt to equity ratio of 0.31.
There are more short-term assets than short-term liabilities on the ATRC balance sheet.
Total ATRC debt is lower than 5 years ago, relative to shareholder equity.
Failed Health Checks:
ATRC earnings of $17.72M is not sufficient to cover its interest payments.
Is Atricure stock a Buy, Hold, or Sell, according to analysts?
Out of 8 Wall Street analysts who give ratings on ATRC, the consensus analyst rating on ATRC is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they financial advice.
Most Recent ATRC Analyst Ratings
Marie Thibault, a top 14% analyst from BTIG maintains ATRC with a strong buy rating and raises their ATRC price target from $45.00 to $55.00, on Aug 24, 2026.
BTIG's Marie Thibault raised their price target on Atricure (NASDAQ: ATRC) by 22.2% from $45 to $55 on 2026/08/24. The analyst maintained their Strong Buy rating on the stock.
Highlighting that only 35% of patients with AF (Atrial fibrillation) who have cardiac surgery in the U.S. receive a surgical ablation, Thibault predicted that AtriCure's new STS Quality Metric could lead to an increase in the use of the EnCompass Clamp in patients with AF who undergo surgery in the coming years.
The analyst posited that this might increase AtriCure's U.S. Open Ablation revenue by $10M to $25M in 2027 and $20M to $55M in 2028.
Priya Sachdeva, a top 35% analyst from UBS maintains ATRC with a strong buy rating and lowers their ATRC price target from $55.00 to $50.00, on Jul 28, 2026.
William Plovanic, a top 14% analyst from Canaccord Genuity maintains ATRC with a strong buy rating and raises their ATRC price target from $53.00 to $55.00, on May 6, 2026.
Last year, ATRC earnings were $10.55M. During the past four year, ATRC's earnings have increased by -35.19% per year. This was slower than the Medical Instruments & Supplies industry average of 5.76%.
Last year, ATRC revenue was $569.62M. In the last 5 year, ATRC's revenue has grown by 18.56% per year. This was faster than the Medical Instruments & Supplies industry average of 10.06%.
No, Atricure doesn't provide an income stream by paying out dividends.
What do other traders have to say about ATRC?
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your ATRC trade
There are two primary types of orders:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are usually the easiest way to buy.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to make sure you're buying or selling at a specific price limit, place a limit order.
Press the Open button and your broker will place the order.
If you require additional help investing in stocks on eToro, watch the how to video below:
As of Nov 2, 2026, it costs $59.88 to buy one share of Atricure stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.167 shares of ATRC.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.